Melanoma News & Features
Link with overall, melanoma-specific survival; increase in CRP also linked to disease progression
Treating metastatic melanoma with a combination of radiotherapy and two immunotherapies that target the CTLA4 and PD-1 pathways could produce an optimal response in more patients.
A new way may have been discovered to more accurately predict the patients likely to respond to genomic-based follow-up therapies, by looking at unique protein patterns in patients with melanoma.
Melanoma in some adolescent and adult patients involve many of the same genetic mutations and would likely respond to the same treatment.
Melanoma screening strategies may be more feasible by focusing on high-risk populations.
- Angelina Jolie has ovaries, fallopian tubes removed over cancer concerns
- Drug sequence with gemcitabine
- Counseling cancer patients on effective nutritional practices
- Radiation plus immunotherapy revs up immune system to better attack melanoma
- Online education tool helps bridge gaps in therapeutic decision-making for NSCLC
- African American cancer patients' depression symptoms often under-recognized
- Advanced thyroid cancer responds to targeted therapy with sunitinib
- Fifteen new breast cancer genetic risk 'hot-spots' revealed
- High fitness level may decrease risk of colorectal, lung cancers
- Discontinuing statin therapy safe, beneficial for patients with terminal illness
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|